Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Molecular Medicine Today|October 1, 1996
Adhesion of multiple myeloma cells to the bone marrow microenvironment: implications for future therapeutic strategiesM B Vidriales, K C AndersonSangre|December 1, 1990
[Non-traumatic rupture of the spleen in malignant hemopathies. 2 new cases]J M Moraleda, M L Vázquez, M B Vidriales, et al.Blood|March 1, 1996
Transforming growth factor-beta1: differential effects on multiple myeloma versus normal B cellsM Urashima, A Ogata, D Chauhan, et al.Leukemia|June 1, 1995
Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studiesA Macedo, A Orfão, M Gonzalez, et al.British Journal of Haematology|February 1, 1995
Immunophenotype of c-kit cells in normal human bone marrow: implications for the detection of minimal residual disease in AMLA Macedo, A Orfao, A Martínez, et al.Blood|September 15, 1996
Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma proteinM Urashima, A Ogata, D Chauhan, et al.Journal of Clinical Pathology|May 1, 1995
Light scatter characteristics of blast cells in acute myeloid leukaemia: association with morphology and immunophenotypeM B Vidriales, A Orfao, M C López-Berges, et al.Journal of Clinical Pathology|January 1, 1996
Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual diseaseA Macedo, J F San Miguel, M B Vidriales, et al.Annals of Hematology|April 1, 1995
Characterization of aberrant phenotypes in acute myeloblastic leukemiaA Macedo, A Orfão, M B Vidriales, et al.British Journal of Haematology|February 1, 1995
Prognostic value of S-phase cells in AML patientsM B Vidriales, A Orfao, M C López-Berges, et al.Pageof 3